- Home
- TCBS vs ITRM Comparison
TCBS vs ITRM Comparison
Compare TCBS & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCBS | ITRM |
|---|---|---|
| Founded | 1934 | 2015 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.3M | 24.3M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | TCBS | ITRM |
|---|---|---|
| Price | $16.30 | $0.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 2.8K | ★ 1.2M |
| Earning Date | 11-07-2025 | 11-14-2025 |
| Dividend Yield | ★ 0.96% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.87 | N/A |
| Revenue | ★ $15,268,000.00 | $390,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $325.95 |
| P/E Ratio | $19.09 | ★ N/A |
| Revenue Growth | ★ 54.88 | N/A |
| 52 Week Low | $14.90 | $0.36 |
| 52 Week High | $19.40 | $2.18 |
Technical Indicators
Market Signals| Indicator | TCBS | ITRM |
|---|---|---|
| Relative Strength Index (RSI) | 59.10 | 43.07 |
| Support Level | $15.90 | $0.44 |
| Resistance Level | $17.00 | $0.48 |
| Average True Range (ATR) | 0.19 | 0.04 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 44.00 | 37.40 |
Price Performance
Historical ComparisonAbout TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.